DYNEX CAPITAL INC (DX) Stock Fundamental Analysis
NYSE:DX - New York Stock Exchange, Inc. - US26817Q8868 - REIT - Currency: USD
Taking everything into account, DX scores 4 out of 10 in our fundamental rating. DX was compared to 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. There are concerns on the financial health of DX while its profitability can be described as average. DX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year DX was profitable.
In the past year DX had a positive cash flow from operations.
Of the past 5 years DX 4 years were profitable.
Each year in the past 5 years DX had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 1.30%, DX belongs to the best of the industry, outperforming 83.08% of the companies in the same industry.
DX has a better Return On Equity (8.96%) than 92.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 8.96% | ||
| ROIC | N/A |
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of DX (33.39%) is better than 92.31% of its industry peers.
DX's Profit Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 1.37%, DX is doing worse than 96.92% of the companies in the same industry.
In the last couple of years the Gross Margin of DX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 33.39% | ||
| GM | 1.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
2. Health
2.1 Basic Checks
DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DX has more shares outstanding
Compared to 5 years ago, DX has more shares outstanding
The debt/assets ratio for DX has been reduced compared to a year ago.
2.2 Solvency
DX has an Altman-Z score of -0.91. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.91, DX is doing worse than 84.62% of the companies in the same industry.
DX has a debt to FCF ratio of 456.03. This is a negative value and a sign of low solvency as DX would need 456.03 years to pay back of all of its debts.
DX has a Debt to FCF ratio of 456.03. This is in the lower half of the industry: DX underperforms 64.62% of its industry peers.
A Debt/Equity ratio of 5.54 is on the high side and indicates that DX has dependencies on debt financing.
With a Debt to Equity ratio value of 5.54, DX is not doing good in the industry: 64.62% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.54 | ||
| Debt/FCF | 456.03 | ||
| Altman-Z | -0.91 |
ROIC/WACCN/A
WACC5.86%
2.3 Liquidity
A Current Ratio of 0.06 indicates that DX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.06, DX is doing worse than 78.46% of the companies in the same industry.
A Quick Ratio of 0.06 indicates that DX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.06, DX is doing worse than 78.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.06 | ||
| Quick Ratio | 0.06 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 107.34% over the past year.
Measured over the past years, DX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.72% on average per year.
DX shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.74%.
Measured over the past years, DX shows a quite strong growth in Revenue. The Revenue has been growing by 13.32% on average per year.
EPS 1Y (TTM)107.34%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)73.74%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%636.65%
3.2 Future
The Earnings Per Share is expected to grow by 76.07% on average over the next years. This is a very strong growth
DX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 248.34% yearly.
EPS Next Y377.12%
EPS Next 2Y134.67%
EPS Next 3Y76.07%
EPS Next 5YN/A
Revenue Next Year908.01%
Revenue Next 2Y248.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 152.56, the valuation of DX can be described as expensive.
69.23% of the companies in the same industry are cheaper than DX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.29. DX is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 8.29, the valuation of DX can be described as very reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as DX.
DX is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 152.56 | ||
| Fwd PE | 8.29 |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, DX is valued a bit more expensive than the industry average as 63.08% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.69 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DX's earnings are expected to grow with 76.07% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y134.67%
EPS Next 3Y76.07%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 16.74%, DX is a good candidate for dividend investing.
DX's Dividend Yield is rather good when compared to the industry average which is at 13.93. DX pays more dividend than 83.08% of the companies in the same industry.
DX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 16.74% |
5.2 History
The dividend of DX decreases each year by -11.72%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
DX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-11.72%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
110.96% of the earnings are spent on dividend by DX. This is not a sustainable payout ratio.
DP110.96%
EPS Next 2Y134.67%
EPS Next 3Y76.07%
NYSE:DX (5/7/2025, 10:39:38 AM)
12.205
+0.09 (+0.7%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners50.1%
Inst Owner Change0.33%
Ins Owners1.05%
Ins Owner Change5.6%
Market Cap1.25B
Analysts84
Price Target13.69 (12.17%)
Short Float %8.2%
Short Ratio1.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 16.74% |
Yearly Dividend1.67
Dividend Growth(5Y)-11.72%
DP110.96%
Div Incr Years0
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-101.98%
Min EPS beat(2)-246.74%
Max EPS beat(2)42.78%
EPS beat(4)2
Avg EPS beat(4)-100.83%
Min EPS beat(4)-246.74%
Max EPS beat(4)42.78%
EPS beat(8)2
Avg EPS beat(8)-229.65%
EPS beat(12)2
Avg EPS beat(12)-163.61%
EPS beat(16)4
Avg EPS beat(16)-122.23%
Revenue beat(2)0
Avg Revenue beat(2)-67.64%
Min Revenue beat(2)-83.68%
Max Revenue beat(2)-51.61%
Revenue beat(4)1
Avg Revenue beat(4)-197%
Min Revenue beat(4)-794.38%
Max Revenue beat(4)141.66%
Revenue beat(8)3
Avg Revenue beat(8)-101.85%
Revenue beat(12)5
Avg Revenue beat(12)-49.21%
Revenue beat(16)6
Avg Revenue beat(16)-37.05%
PT rev (1m)-5.29%
PT rev (3m)-1.23%
EPS NQ rev (1m)-1.04%
EPS NQ rev (3m)105.25%
EPS NY rev (1m)-0.88%
EPS NY rev (3m)39.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.32%
Revenue NY rev (1m)21.9%
Revenue NY rev (3m)27.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 152.56 | ||
| Fwd PE | 8.29 | ||
| P/S | 3.92 | ||
| P/FCF | 86.69 | ||
| P/OCF | 86.69 | ||
| P/B | 1.05 | ||
| P/tB | 1.05 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.08
EY0.66%
EPS(NY)1.47
Fwd EY12.07%
FCF(TTM)0.14
FCFY1.15%
OCF(TTM)0.14
OCFY1.15%
SpS3.11
BVpS11.59
TBVpS11.59
PEG (NY)0.4
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 8.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 33.39% | ||
| GM | 1.37% | ||
| FCFM | 4.53% |
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
F-Score7
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.54 | ||
| Debt/FCF | 456.03 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | 13.55% | ||
| Current Ratio | 0.06 | ||
| Quick Ratio | 0.06 | ||
| Altman-Z | -0.91 |
F-Score7
WACC5.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.34%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y377.12%
EPS Next 2Y134.67%
EPS Next 3Y76.07%
EPS Next 5YN/A
Revenue 1Y (TTM)73.74%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%636.65%
Revenue Next Year908.01%
Revenue Next 2Y248.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y72.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-76.86%
FCF growth 3Y-53.91%
FCF growth 5Y-39.34%
OCF growth 1Y-76.86%
OCF growth 3Y-53.91%
OCF growth 5Y-39.34%